CLINICAL_TRIALS
trial_result
· 2010-02-01
Clinical Trial Update: Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080) [Phase 1]
Summary
A Phase 1 fed bioequivalence study of sitagliptin/metformin (0431A-080) completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2010-02-01